Vitamin B6 Analog [EPC]

Vitamin B6 Analog [EPC] was reported 363 times

Drugs of the Vitamin B6 Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 URETHRAL SPASM 1 0.0192
1 VASCULAR ACCESS SITE BRUISING 1 0.0185
2 EXTERNAL EAR INFLAMMATION 2 0.0161
3 DYSANIA 1 0.0130
4 LARYNGITIS VIRAL 1 0.0094
5 HYPOGLOBULINAEMIA 1 0.0088
6 CIRCUMCISION 1 0.0071
7 SPLINTER 1 0.0043
8 CHRONIC DISEASE 1 0.0039
9 ECZEMA INFECTED 1 0.0037
10 INFUSION SITE MASS 4 0.0037
11 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 1 0.0034
12 SMOKE SENSITIVITY 1 0.0032
13 ALLERGY TO VACCINE 1 0.0032
14 NOROVIRUS TEST POSITIVE 1 0.0031
15 AMINO ACID LEVEL DECREASED 1 0.0030
16 GIARDIASIS 1 0.0029
17 BIOPSY LUNG 1 0.0027
18 SENSATION OF BLOOD FLOW 1 0.0026
19 OROPHARYNGEAL SPASM 1 0.0024
20 INFUSION SITE IRRITATION 3 0.0023
21 ALLERGY TO PLANTS 1 0.0022
22 INFUSION SITE NODULE 2 0.0021
23 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
24 SPLENIC HAEMORRHAGE 1 0.0020
25 CYST REMOVAL 1 0.0019
26 INFUSION SITE VESICLES 1 0.0019
27 INFUSION SITE CELLULITIS 1 0.0019
28 EPHELIDES 1 0.0019
29 MORNING SICKNESS 1 0.0018
30 HEAD BANGING 1 0.0018
31 ROTAVIRUS INFECTION 1 0.0017
32 INFUSION SITE DISCHARGE 3 0.0017
33 INDUCED LABOUR 1 0.0017
34 MEAN PLATELET VOLUME INCREASED 1 0.0017
35 BLOOD VISCOSITY INCREASED 1 0.0017
36 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
37 SHORT-BOWEL SYNDROME 1 0.0015
38 INFUSION SITE HAEMORRHAGE 5 0.0015
39 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
40 HAEMATOSPERMIA 1 0.0014
41 INFUSION SITE BRUISING 3 0.0014
42 SQUAMOUS CELL CARCINOMA OF LUNG 1 0.0013
43 CRITICAL ILLNESS 1 0.0013
44 VASCULAR ACCESS COMPLICATION 1 0.0012
45 HEPATIC CANCER METASTATIC 1 0.0012
46 HEPATIC HAEMORRHAGE 1 0.0012
47 SOLILOQUY 1 0.0012
48 PROTEIN URINE 1 0.0011
49 ADVERSE FOOD REACTION 1 0.0011
50 CEREBELLAR ATAXIA 1 0.0010
51 DUST ALLERGY 1 0.0010
52 INFUSION SITE DISCOMFORT 1 0.0010
53 CORTISOL DECREASED 1 0.0009
54 CARBON DIOXIDE DECREASED 1 0.0009
55 REACTION TO EXCIPIENT 2 0.0009
56 SYSTEMIC MYCOSIS 1 0.0009
57 INFUSION SITE ERYTHEMA 7 0.0008
58 PROSTATIC OPERATION 1 0.0008
59 POST-ACUTE COVID-19 SYNDROME 1 0.0008
60 APPLICATION SITE WARMTH 1 0.0008
61 DACRYOSTENOSIS ACQUIRED 1 0.0008
62 ANION GAP INCREASED 1 0.0007
63 CARBON DIOXIDE INCREASED 1 0.0007
64 CYSTIC FIBROSIS 4 0.0007
65 MAST CELL ACTIVATION SYNDROME 1 0.0007
66 CATAPLEXY 1 0.0007
67 GENITAL RASH 1 0.0007
68 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
69 NORMOCYTIC ANAEMIA 1 0.0007
70 INFUSION SITE REACTION 2 0.0007
71 MOUTH INJURY 1 0.0007
72 INFUSION SITE PRURITUS 2 0.0006
73 NASAL ULCER 1 0.0006
74 TINEA PEDIS 1 0.0006
75 INFUSION SITE PAIN 8 0.0006
76 OXYGEN THERAPY 1 0.0006
77 MEDICAL PROCEDURE 1 0.0006
78 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
79 SEIZURE LIKE PHENOMENA 1 0.0006
80 BLOOD CHLORIDE INCREASED 1 0.0006
81 SENSITIVITY OF TEETH 1 0.0006
82 ILEAL STENOSIS 1 0.0006
83 OPHTHALMIC HERPES ZOSTER 1 0.0006
84 ADRENAL DISORDER 1 0.0005
85 JOINT NOISE 1 0.0005
86 VOCAL CORD DISORDER 1 0.0005
87 GENE MUTATION 1 0.0005
88 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
89 PHYSICAL ASSAULT 1 0.0005
90 INFUSION SITE SWELLING 3 0.0005
91 EXOPHTHALMOS 1 0.0005
92 PRODUCT FORMULATION ISSUE 3 0.0005
93 COLONOSCOPY 1 0.0005
94 MIDDLE EAR EFFUSION 1 0.0005
95 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
96 BLOOD LOSS ANAEMIA 1 0.0004
97 EAR DISORDER 2 0.0004
98 DISCOURAGEMENT 1 0.0004
99 PUSTULE 1 0.0004
100 STARING 1 0.0004
101 DENTAL OPERATION 1 0.0004
102 HYPERVOLAEMIA 2 0.0004
103 PENIS DISORDER 1 0.0004
104 DEVICE INFUSION ISSUE 1 0.0004
105 EYELID IRRITATION 1 0.0004
106 METASTASES TO PERITONEUM 1 0.0004
107 ENDODONTIC PROCEDURE 1 0.0004
108 ACTINIC KERATOSIS 1 0.0004
109 RETINAL DISORDER 1 0.0004
110 COMPARTMENT SYNDROME 1 0.0004
111 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
112 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
113 GAMBLING DISORDER 1 0.0004
114 WOUND INFECTION 4 0.0004
115 ELECTRIC SHOCK SENSATION 1 0.0004
116 PRODUCT LEAKAGE 2 0.0004
117 OXYGEN SATURATION ABNORMAL 1 0.0004
118 INJECTION SITE SCAR 1 0.0004
119 TUMOUR HAEMORRHAGE 1 0.0004
120 PSEUDOMONAS INFECTION 3 0.0003
121 LIP PAIN 1 0.0003
122 VOMITING PROJECTILE 1 0.0003
123 SKIN WARM 2 0.0003
124 BLOOD IRON DECREASED 4 0.0003
125 ATYPICAL PNEUMONIA 1 0.0003
126 SYMPTOM RECURRENCE 2 0.0003
127 HYPERCAPNIA 1 0.0003
128 KERATITIS 1 0.0003
129 BLOOD BLISTER 1 0.0003
130 BLADDER PAIN 1 0.0003
131 SCREAMING 2 0.0003
132 EAR PRURITUS 1 0.0003
133 FACIAL PARESIS 1 0.0003
134 MONOCYTE COUNT INCREASED 1 0.0003
135 FREEZING PHENOMENON 1 0.0003
136 THROAT CLEARING 1 0.0003
137 EYE INFECTION 3 0.0003
138 AUTOIMMUNE THYROIDITIS 1 0.0003
139 PARANASAL SINUS HYPERSECRETION 1 0.0003
140 COMMUNICATION DISORDER 1 0.0003
141 GASTRIC INFECTION 1 0.0003
142 THYROID MASS 1 0.0003
143 TRIGEMINAL NEURALGIA 1 0.0002
144 ORGAN FAILURE 1 0.0002
145 FUNGAL SKIN INFECTION 1 0.0002
146 HOMICIDAL IDEATION 1 0.0002
147 RECURRENT CANCER 1 0.0002
148 TRIGGER FINGER 1 0.0002
149 SELF-MEDICATION 1 0.0002
150 THYROID FUNCTION TEST ABNORMAL 1 0.0002
151 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
152 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
153 PRODUCT DISPENSING ISSUE 1 0.0002
154 DEVICE OPERATIONAL ISSUE 1 0.0002
155 OCULAR ICTERUS 1 0.0002
156 PULMONARY FUNCTION TEST DECREASED 1 0.0002
157 MELANOCYTIC NAEVUS 1 0.0002
158 ONYCHOMYCOSIS 1 0.0002
159 SARS-COV-2 TEST POSITIVE 3 0.0002
160 LIGAMENT RUPTURE 1 0.0002
161 URINE ABNORMALITY 1 0.0002
162 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
163 ABDOMINAL HERNIA 1 0.0002
164 RENAL FUNCTION TEST ABNORMAL 1 0.0002
165 FEELING OF DESPAIR 1 0.0002
166 PULSE ABSENT 1 0.0002
167 DIZZINESS POSTURAL 2 0.0002
168 AUTOIMMUNE DISORDER 2 0.0002
169 PHARYNGEAL SWELLING 2 0.0002
170 INSURANCE ISSUE 3 0.0002
171 PERIORBITAL OEDEMA 1 0.0002
172 MALABSORPTION 1 0.0002
173 CATATONIA 1 0.0002
174 RASH ERYTHEMATOUS 9 0.0002
175 EAR INFECTION 5 0.0002
176 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
177 HEREDITARY ANGIOEDEMA 2 0.0002
178 INJECTION SITE DISCHARGE 1 0.0002
179 BEHAVIOUR DISORDER 1 0.0002
180 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
181 FOOT DEFORMITY 2 0.0002
182 DERMATITIS CONTACT 2 0.0002
183 SKIN ATROPHY 1 0.0002
184 MOUTH SWELLING 1 0.0002
185 ENERGY INCREASED 1 0.0002
186 CARDIAC PACEMAKER INSERTION 1 0.0002
187 MACULAR DEGENERATION 2 0.0002
188 PLATELET COUNT ABNORMAL 1 0.0002
189 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
190 INGUINAL HERNIA 1 0.0002
191 DERMATITIS ACNEIFORM 1 0.0002
192 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
193 INFUSION SITE EXTRAVASATION 1 0.0002
194 NASAL DRYNESS 1 0.0002
195 ROTATOR CUFF SYNDROME 2 0.0002
196 THERAPY NON-RESPONDER 7 0.0002
197 SOMNAMBULISM 1 0.0002
198 WALKING AID USER 1 0.0002
199 ADVERSE REACTION 2 0.0002
200 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
201 HAIR GROWTH ABNORMAL 1 0.0001
202 SEASONAL ALLERGY 2 0.0001
203 HYPOKINESIA 2 0.0001
204 CRYING 5 0.0001
205 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
206 SINUSITIS 14 0.0001
207 MOUTH HAEMORRHAGE 1 0.0001
208 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
209 FEELING DRUNK 1 0.0001
210 ORAL PAIN 3 0.0001
211 SNEEZING 3 0.0001
212 AORTIC ANEURYSM 1 0.0001
213 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
214 FOOD ALLERGY 1 0.0001
215 ATRIOVENTRICULAR BLOCK 1 0.0001
216 FLUSHING 13 0.0001
217 BRAIN FOG 2 0.0001
218 MULTIPLE ALLERGIES 1 0.0001
219 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
220 RESPIRATORY TRACT CONGESTION 2 0.0001
221 PREMATURE DELIVERY 2 0.0001
222 RHINITIS 1 0.0001
223 MUSCLE DISORDER 1 0.0001
224 POST PROCEDURAL INFECTION 1 0.0001
225 DECUBITUS ULCER 1 0.0001
226 POLYURIA 1 0.0001
227 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
228 MENSTRUAL DISORDER 1 0.0001
229 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
230 VIRAL INFECTION 4 0.0001
231 PRODUCT COMPLAINT 3 0.0001
232 BLOOD MAGNESIUM DECREASED 1 0.0001
233 CARDIAC MURMUR 1 0.0001
234 RASH MACULAR 4 0.0001
235 BLOOD CALCIUM INCREASED 1 0.0001
236 THERAPY INTERRUPTED 8 0.0001
237 GASTROINTESTINAL INFECTION 1 0.0001
238 RETINAL DETACHMENT 1 0.0001
239 BACTERIAL INFECTION 2 0.0001
240 BLOOD URINE PRESENT 2 0.0001
241 INTENTIONAL DOSE OMISSION 3 0.0001
242 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
243 PRODUCT SUBSTITUTION ISSUE 6 0.0001
244 ERUCTATION 2 0.0001
245 EAR PAIN 2 0.0001
246 LABORATORY TEST ABNORMAL 3 0.0001
247 LIGAMENT SPRAIN 1 0.0001
248 SINUS DISORDER 2 0.0001
249 COMPLICATION OF DEVICE INSERTION 2 0.0001
250 ADVERSE DRUG REACTION 9 0.0001
251 INFLUENZA 11 0.0001
252 TOOTH ABSCESS 1 0.0001
253 SLUGGISHNESS 1 0.0001
254 NEUTROPHIL COUNT INCREASED 1 0.0001
255 INITIAL INSOMNIA 1 0.0001
256 EAR DISCOMFORT 1 0.0001
257 EYE DISCHARGE 1 0.0001
258 TRANSFUSION 1 0.0001
259 MOUTH ULCERATION 2 0.0001
260 DERMATITIS ATOPIC 5 0.0001
261 INCONTINENCE 1 0.0001
262 FULL BLOOD COUNT ABNORMAL 1 0.0001
263 RENAL PAIN 1 0.0001
264 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
265 BREAST PAIN 1 0.0001
266 PHARYNGITIS STREPTOCOCCAL 1 0.0001
267 SKIN LACERATION 1 0.0001
268 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
269 ASPIRATION 1 0.0001
270 TOOTH FRACTURE 1 0.0001
271 THROAT IRRITATION 4 0.0001
272 SKIN INFECTION 1 0.0001
273 MITRAL VALVE INCOMPETENCE 1 0.0001
274 IMPAIRED DRIVING ABILITY 1 0.0001
275 SCAB 1 0.0001
276 MICTURITION URGENCY 1 0.0001
277 NEOPLASM 1 0.0001
278 EYE IRRITATION 5 0.0001
279 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
280 METASTASES TO LUNG 1 0.0001
281 SPINAL PAIN 1 0.0001
282 DISCOMFORT 5 0.0001
283 GENERALISED OEDEMA 1 0.0001
284 CYST 1 0.0001
285 INJECTION SITE DISCOLOURATION 1 0.0001
286 HOT FLUSH 6 0.0001
287 DERMATITIS ALLERGIC 1 0.0001
288 HOSPITALISATION 12 0.0001
289 MYDRIASIS 1 0.0001
290 ILLNESS 8 0.0001
291 SKIN ULCER 2 0.0001
292 HIATUS HERNIA 1 0.0001
293 HAEMATOMA 2 0.0001
294 IMMUNE SYSTEM DISORDER 1 0.0001
295 HYPERSENSITIVITY 14 0.0001
296 EYE HAEMORRHAGE 1 0.0001
297 HAIR TEXTURE ABNORMAL 1 0.0001
298 QUALITY OF LIFE DECREASED 1 0.0001
299 SINUS CONGESTION 1 0.0001
300 IMPAIRED GASTRIC EMPTYING 1 0.0001
301 GINGIVAL BLEEDING 1 0.0001
302 ORAL DISCOMFORT 1 0.0001
303 HUNGER 1 0.0001
304 ROAD TRAFFIC ACCIDENT 3 0.0001
305 COORDINATION ABNORMAL 1 0.0001
306 CARPAL TUNNEL SYNDROME 1 0.0001
307 COUGH 20 0.0001
308 DIALYSIS 1 0.0001
309 IMPAIRED QUALITY OF LIFE 1 0.0001
310 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
311 COVID-19 12 0.0001
312 BONE PAIN 4 0.0001
313 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
314 IMMUNODEFICIENCY 1 0.0001
315 HYPOAESTHESIA ORAL 1 0.0001
316 FEELING HOT 4 0.0001
317 THYROID DISORDER 1 0.0001
318 LYMPHOMA 1 0.0001
319 LIMB DISCOMFORT 2 0.0001
320 BASAL CELL CARCINOMA 1 0.0001
321 ARTHRITIS 5 0.0001
322 CYSTITIS 2 0.0001
323 OBESITY 1 0.0001
324 NIGHT SWEATS 2 0.0001
325 RHINORRHOEA 4 0.0001
326 BACK DISORDER 1 0.0001
327 PRODUCT DOSE OMISSION 4 0.0001
328 STAPHYLOCOCCAL INFECTION 2 0.0001
329 PHOTOSENSITIVITY REACTION 1 0.0001
330 LIP SWELLING 2 0.0001
331 SKIN DISORDER 2 0.0001
332 AGGRESSION 3 0.0001
333 URINARY RETENTION 2 0.0001
334 BLOOD UREA INCREASED 1 0.0001
335 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
336 ANGER 2 0.0001
337 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
338 SCAR 1 0.0001
339 NIGHTMARE 2 0.0001
340 DEVICE DEFECTIVE 1 0.0001
341 ABDOMINAL DISTENSION 6 0.0001
342 DEVICE USE ISSUE 1 0.0001
343 PRODUCT STORAGE ERROR 5 0.0001
344 SLEEP DISORDER 4 0.0001
345 LYMPHOCYTE COUNT DECREASED 1 0.0001
346 DRUG ERUPTION 1 0.0001
347 THIRST 1 0.0001
348 GOUT 1 0.0001
349 GASTROENTERITIS VIRAL 1 0.0001
350 BRONCHITIS 4 0.0001
351 CONJUNCTIVITIS 1 0.0001
352 URTICARIA 9 0.0001
353 MIDDLE INSOMNIA 1 0.0001
354 OXYGEN SATURATION DECREASED 3 0.0001
355 EYE PAIN 3 0.0001
356 PHOTOPHOBIA 1 0.0001
357 DYSARTHRIA 2 0.0001
358 BLOOD SODIUM DECREASED 1 0.0001
359 FOOT FRACTURE 1 0.0001
360 PROTEINURIA 1 0.0001
361 DIABETES MELLITUS 4 0.0001
362 INCREASED APPETITE 1 0.0001
363 HERPES ZOSTER 3 0.0001
364 LETHARGY 3 0.0001
365 PULMONARY FIBROSIS 1 0.0001
366 DRUG PRESCRIBING ERROR 1 0.0001
367 ACUTE RESPIRATORY FAILURE 1 0.0001
368 PERIPHERAL SWELLING 8 0.0001
369 GLAUCOMA 1 0.0001
370 DRUG INTOLERANCE 5 0.0001
371 HERNIA 1 0.0001
372 ABDOMINAL PAIN 12 0.0001
373 SURGERY 3 0.0001
374 NASAL CONGESTION 3 0.0001
375 PRODUCT DOSE OMISSION ISSUE 15 0.0001
376 KIDNEY INFECTION 1 0.0001
377 DYSPEPSIA 5 0.0001
378 WHEEZING 3 0.0001
379 DISABILITY 1 0.0001
380 ABNORMAL BEHAVIOUR 2 0.0001
381 HAEMATOCRIT DECREASED 1 0.0001
382 CATARACT 3 0.0001
383 UPPER LIMB FRACTURE 1 0.0001
384 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
385 FULL BLOOD COUNT DECREASED 1 0.0000
386 PRODUCT PHYSICAL ISSUE 1 0.0000
387 FEEDING DISORDER 1 0.0000
388 TASTE DISORDER 1 0.0000
389 INJECTION SITE WARMTH 1 0.0000
390 RIB FRACTURE 1 0.0000
391 ABDOMINAL PAIN UPPER 10 0.0000
392 EATING DISORDER 1 0.0000
393 RETCHING 1 0.0000
394 IRRITABLE BOWEL SYNDROME 1 0.0000
395 LIVER FUNCTION TEST INCREASED 1 0.0000
396 HYPOACUSIS 2 0.0000
397 POOR QUALITY SLEEP 1 0.0000
398 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
399 DEVICE LEAKAGE 2 0.0000
400 DIZZINESS 23 0.0000
401 VAGINAL HAEMORRHAGE 2 0.0000
402 PRODUCT PRESCRIBING ISSUE 1 0.0000
403 RASH 20 0.0000
404 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
405 STEVENS-JOHNSON SYNDROME 1 0.0000
406 GLOSSODYNIA 1 0.0000
407 RASH PAPULAR 1 0.0000
408 HEART RATE IRREGULAR 1 0.0000
409 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
410 SKIN IRRITATION 2 0.0000
411 MUSCLE TWITCHING 1 0.0000
412 SEIZURE 5 0.0000
413 PERICARDIAL EFFUSION 1 0.0000
414 OROPHARYNGEAL PAIN 4 0.0000
415 PRODUCT PRESCRIBING ERROR 1 0.0000
416 PRODUCTIVE COUGH 2 0.0000
417 ABDOMINAL DISCOMFORT 7 0.0000
418 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
419 CONTUSION 4 0.0000
420 LOCALISED INFECTION 1 0.0000
421 NEURALGIA 1 0.0000
422 INJECTION SITE URTICARIA 1 0.0000
423 PNEUMONIA 13 0.0000
424 HYPOAESTHESIA 6 0.0000
425 DRY EYE 2 0.0000
426 PNEUMONIA ASPIRATION 1 0.0000
427 UNEVALUABLE EVENT 3 0.0000
428 ACNE 3 0.0000
429 PRURITUS 15 0.0000
430 HAEMOGLOBIN DECREASED 4 0.0000
431 UNRESPONSIVE TO STIMULI 1 0.0000
432 RASH GENERALISED 1 0.0000
433 RESPIRATORY TRACT INFECTION 1 0.0000
434 DEAFNESS 1 0.0000
435 JOINT STIFFNESS 1 0.0000
436 DEPRESSED MOOD 2 0.0000
437 INSOMNIA 10 0.0000
438 DEHYDRATION 5 0.0000
439 DRY SKIN 5 0.0000
440 PRODUCT USE ISSUE 7 0.0000
441 DYSPNOEA 21 0.0000
442 BLOOD BILIRUBIN INCREASED 1 0.0000
443 THROAT TIGHTNESS 1 0.0000
444 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
445 PALLOR 1 0.0000
446 MOOD ALTERED 1 0.0000
447 MEMORY IMPAIRMENT 5 0.0000
448 ABNORMAL DREAMS 1 0.0000
449 ARTHRALGIA 15 0.0000
450 MENTAL STATUS CHANGES 1 0.0000
451 DEMENTIA 1 0.0000
452 RENAL IMPAIRMENT 3 0.0000
453 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
454 FLATULENCE 2 0.0000
455 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
456 RED BLOOD CELL COUNT DECREASED 1 0.0000
457 SOMNOLENCE 7 0.0000
458 BALANCE DISORDER 3 0.0000
459 FATIGUE 27 0.0000
460 DECREASED APPETITE 8 0.0000
461 NEEDLE ISSUE 1 0.0000
462 MUSCULOSKELETAL STIFFNESS 3 0.0000
463 MALAISE 15 0.0000
464 ERYTHEMA 7 0.0000
465 RESPIRATORY DISORDER 1 0.0000
466 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
467 BLOOD POTASSIUM DECREASED 1 0.0000
468 PREMATURE BABY 1 0.0000
469 LACRIMATION INCREASED 1 0.0000
470 PLEURAL EFFUSION 2 0.0000
471 BLOOD PRESSURE INCREASED 5 0.0000
472 MUSCLE SPASMS 6 0.0000
473 INJECTION SITE RASH 1 0.0000
474 NASOPHARYNGITIS 6 0.0000
475 VISUAL IMPAIRMENT 4 0.0000
476 WEIGHT DECREASED 9 0.0000
477 HEADACHE 20 0.0000
478 DYSPHAGIA 3 0.0000
479 NEUROPATHY PERIPHERAL 3 0.0000
480 MIGRAINE 3 0.0000
481 METABOLIC ACIDOSIS 1 0.0000
482 WEIGHT INCREASED 7 0.0000
483 DIARRHOEA 20 0.0000
484 SWELLING FACE 2 0.0000
485 IMPAIRED HEALING 1 0.0000
486 VISUAL ACUITY REDUCED 1 0.0000
487 EXPIRED PRODUCT ADMINISTERED 1 0.0000
488 FUNGAL INFECTION 1 0.0000
489 GAIT INABILITY 1 0.0000
490 HYPOTENSION 6 0.0000
491 TYPE 2 DIABETES MELLITUS 1 0.0000
492 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
493 URINARY TRACT INFECTION 5 0.0000
494 CHEST DISCOMFORT 3 0.0000
495 FEELING ABNORMAL 7 0.0000
496 DEVICE USE ERROR 1 0.0000
497 HAEMORRHAGE 3 0.0000
498 BURNING SENSATION 2 0.0000
499 HEART RATE DECREASED 1 0.0000
500 PLATELET COUNT DECREASED 3 0.0000
501 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
502 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
503 NAUSEA 22 0.0000
504 VOMITING 13 0.0000
505 INFECTION 4 0.0000
506 CONSTIPATION 6 0.0000
507 ACCIDENTAL OVERDOSE 1 0.0000
508 AGITATION 2 0.0000
509 DYSURIA 1 0.0000
510 FALL 9 0.0000
511 CHEST PAIN 5 0.0000
512 DYSGEUSIA 2 0.0000
513 EYE SWELLING 1 0.0000
514 HEPATIC FUNCTION ABNORMAL 1 0.0000
515 EPISTAXIS 2 0.0000
516 DYSPNOEA EXERTIONAL 1 0.0000
517 MUSCULAR WEAKNESS 3 0.0000
518 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
519 PYREXIA 9 0.0000
520 PLASMA CELL MYELOMA 1 0.0000
521 PALPITATIONS 3 0.0000
522 CHILLS 3 0.0000
523 PARAESTHESIA 4 0.0000
524 DISORIENTATION 1 0.0000
525 DRY MOUTH 2 0.0000
526 DYSKINESIA 1 0.0000
527 CARDIAC ARREST 2 0.0000
528 TREMOR 4 0.0000
529 RHABDOMYOLYSIS 1 0.0000
530 WITHDRAWAL SYNDROME 1 0.0000
531 CONDITION AGGRAVATED 7 0.0000
532 DEVICE DISLOCATION 1 0.0000
533 MENTAL DISORDER 1 0.0000
534 PAIN 14 0.0000
535 ANGIOEDEMA 1 0.0000
536 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
537 COLITIS ULCERATIVE 1 0.0000
538 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
539 GASTROINTESTINAL DISORDER 2 0.0000
540 VISION BLURRED 3 0.0000
541 TINNITUS 1 0.0000
542 RENAL DISORDER 1 0.0000
543 BLOOD CHOLESTEROL INCREASED 1 0.0000
544 CARDIAC DISORDER 2 0.0000
545 SWELLING 2 0.0000
546 OCULAR HYPERAEMIA 1 0.0000
547 PAIN IN EXTREMITY 6 0.0000
548 HEART RATE INCREASED 2 0.0000
549 SYNCOPE 2 0.0000
550 CELLULITIS 1 0.0000
551 FLUID RETENTION 1 0.0000
552 THERAPY CESSATION 1 0.0000
553 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
554 INFLAMMATION 1 0.0000
555 ECZEMA 1 0.0000
556 MUSCULOSKELETAL PAIN 1 0.0000
557 SPEECH DISORDER 1 0.0000
558 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
559 CONFUSIONAL STATE 3 0.0000
560 DISTURBANCE IN ATTENTION 1 0.0000
561 RASH PRURITIC 1 0.0000
562 ANAPHYLACTIC REACTION 1 0.0000
563 NECK PAIN 1 0.0000
564 BLISTER 1 0.0000
565 HYPONATRAEMIA 1 0.0000
566 ASTHMA 2 0.0000
567 INCORRECT DOSE ADMINISTERED 4 0.0000
568 BLADDER CANCER 1 0.0000
569 DISEASE PROGRESSION 2 0.0000
570 IRRITABILITY 1 0.0000
571 JOINT SWELLING 2 0.0000
572 THERAPEUTIC RESPONSE DECREASED 1 0.0000
573 STOMATITIS 1 0.0000
574 ILL-DEFINED DISORDER 1 0.0000
575 OEDEMA PERIPHERAL 2 0.0000
576 VERTIGO 1 0.0000
577 INJECTION SITE PAIN 5 0.0000
578 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
579 INJECTION SITE ERYTHEMA 2 0.0000
580 OFF LABEL USE 14 0.0000
581 ASTHENIA 6 0.0000
582 GAIT DISTURBANCE 3 0.0000
583 HYPERHIDROSIS 2 0.0000
584 DEEP VEIN THROMBOSIS 1 0.0000
585 AMNESIA 1 0.0000
586 BLOOD CREATININE INCREASED 1 0.0000
587 DEATH 13 0.0000
588 NEOPLASM MALIGNANT 1 0.0000
589 INJECTION SITE PRURITUS 1 0.0000
590 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
591 INJECTION SITE REACTION 1 0.0000
592 DEVICE MALFUNCTION 1 0.0000
593 INJURY 1 0.0000
594 ANXIETY 4 0.0000
595 SKIN BURNING SENSATION 1 0.0000
596 MOBILITY DECREASED 1 0.0000
597 UNDERDOSE 1 0.0000
598 HALLUCINATION 1 0.0000
599 BACK PAIN 3 0.0000
600 INJECTION SITE BRUISING 1 0.0000
601 INJECTION SITE HAEMORRHAGE 1 0.0000
602 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
603 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
604 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
605 SKIN EXFOLIATION 1 0.0000
606 INTENTIONAL PRODUCT MISUSE 1 0.0000
607 TACHYCARDIA 1 0.0000
608 DEVICE ISSUE 1 0.0000
609 NO ADVERSE EVENT 2 0.0000
610 SUICIDAL IDEATION 1 0.0000
611 ADVERSE EVENT 1 0.0000
612 BREAST CANCER 1 0.0000
613 DRUG INEFFECTIVE 14 0.0000
614 BLOOD GLUCOSE INCREASED 2 0.0000
615 ATRIAL FIBRILLATION 1 0.0000
616 ALOPECIA 2 0.0000
617 HYPERTENSION 2 0.0000
618 THROMBOCYTOPENIA 1 0.0000
619 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
620 RENAL FAILURE 1 0.0000
621 PRODUCT QUALITY ISSUE 1 0.0000
622 CEREBROVASCULAR ACCIDENT 1 0.0000
623 MYALGIA 1 0.0000
624 DEPRESSION 1 0.0000